Your Shopping Cart is empty.

${{ (item.variation.media ? item.variation.media.alt_translations : item.product.cover_media.alt_translations) | translateModel }}$ ${{ (item.variation.media ? item.variation.media.alt_translations : item.product.cover_media.alt_translations) | translateModel }}$

{{ childProduct.title_translations | translateModel }}

{{ getChildVariationShorthand(childProduct.child_variation) }}

{{ getSelectedItemDetail(selectedChildProduct, item).childProductName }} x {{ selectedChildProduct.quantity || 1 }}

{{ getSelectedItemDetail(selectedChildProduct, item).childVariationName }}

{{item.quantity}}x NT$0 {{ item.unit_point }} Point

Remove

${{addonItem.product.cover_media.alt_translations | translateModel}}$

{{addonItem.quantity}}x {{ mainConfig.merchantData.base_currency.alternate_symbol + "0" }}

Remove

UC-II and Joint Health: The Science of Undenatured Type II Collagen

Introduction

Joint discomfort and reduced mobility are common issues associated with aging, physical stress, and cartilage degeneration. UC-II®, a patented form of undenatured type II collagen, offers a novel mechanism for supporting joint health through immune modulation rather than traditional cartilage supplementation.

What Is UC-II?

UC-II is derived from chicken sternum cartilage and retains its native (undenatured) triple-helix structure. Unlike hydrolyzed collagen, UC-II works by inducing oral tolerance, training the immune system to reduce inflammation-driven joint degradation.

Mechanism of Action

Immune Tolerance: UC-II interacts with Peyer’s patches in the small intestine to modulate T-cell response, promoting joint homeostasis.
Cartilage Preservation: It helps reduce enzymatic degradation of cartilage and supports the regeneration of collagen matrix within joints.

Scientific Evidence

A randomized, double-blind, placebo-controlled study published in International Journal of Medical Sciences (2009) demonstrated that 40 mg of UC-II daily significantly improved knee function and flexibility in osteoarthritis patients.
In a separate trial with healthy, active adults, UC-II improved joint range of motion and reduced post-exercise soreness over 120 days.

UC-II vs. Other Joint Ingredients

Hydrolyzed Collagen: Provides amino acids but lacks immunomodulatory effects.
Glucosamine & Chondroitin: May offer joint lubrication but less support for immune-driven inflammation.

Recommended Use

UC-II is typically effective at a low daily dose of 40 mg and can be taken with or without food. It is well-tolerated and suitable for long-term joint maintenance.

Conclusion

UC-II represents a new frontier in joint health supplementation, offering targeted immune support and cartilage protection through undenatured collagen science. It provides a promising option for both aging populations and active individuals seeking long-term joint function.

References

Lugo JP, et al. "Undenatured type II collagen (UC-II) for joint support: a randomized trial." Int J Med Sci. 2009.
Bagchi D, et al. "Effects of UC-II on joint function in healthy individuals: a 120-day study." J Aging Res Clin Pract. 2015.